Long-term efficacy and safety of azathioprine in ulcerative colitis

21Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and aims: Azathioprine (AZA) is an established treatment for ulcerative colitis (UC). However, controversy exists regarding its efficacy in inducing and maintaining clinical remission, and long-term data are lacking. We studied the effectiveness of AZA in a large cohort of UC patients treated in a single center. Methods: All UC patients treated with AZA were identified from a prospective electronic database. We assessed response to therapy at 4 months and sustained clinical benefit at the last point of follow-up. We also examined predictors of response and sustained clinical benefit, as well as outcomes in those treated with AZA for > 5 years. Results: The study included 255 patients. At 4 months, 207 (81.2%) of 255 patients were still on AZA and 163 (63.9%) had responded to therapy. At the last point of follow-up 164 (64.3%) patients were still receiving AZA, of whom 154 (60.4%) achieved sustained clinical benefit. This effect was durable among 71 patients who received AZA for > 5 years, with 61 (85.9%) considered to have achieved sustained clinical benefit. Twenty-six patients required admission to hospital for an exacerbation during AZA treatment, 20 patients ultimately required biologic therapy, and 21 underwent colectomy. Only two (2.8%) of 71 patients receiving AZA for > 5 years needed to escalate to a biologic therapy, and only one (1.4%) required a colectomy. Conclusions: AZA is a safe and effective therapy in UC patients who fail 5-aminosalisylates in both the short and long term. Escalation to a biologic therapy or colectomy was unlikely among patients who were able to continue AZA therapy beyond 5 years.

References Powered by Scopus

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

2856Citations
N/AReaders
Get full text

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

2546Citations
N/AReaders
Get full text

Guidelines for the management of inflammatory bowel disease in adults

1114Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Management of paediatric ulcerative colitis, part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

351Citations
N/AReaders
Get full text

Oxidative stress and effect of treatment on the oxidation product decomposition processes in IBD

78Citations
N/AReaders
Get full text

Use of thiopurines in inflammatory bowel disease: an update

56Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sood, R., Ansari, S., Clark, T., Hamlin, P. J., & Ford, A. C. (2015). Long-term efficacy and safety of azathioprine in ulcerative colitis. Journal of Crohn’s and Colitis, 9(2), 191–197. https://doi.org/10.1093/ecco-jcc/jju010

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

65%

Researcher 6

16%

Professor / Associate Prof. 5

14%

Lecturer / Post doc 2

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 28

74%

Pharmacology, Toxicology and Pharmaceut... 5

13%

Biochemistry, Genetics and Molecular Bi... 3

8%

Computer Science 2

5%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 6

Save time finding and organizing research with Mendeley

Sign up for free